Benjamin Edwards’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$658K Sell
1,054
-330
-24% -$193K 0.01% 964
2026
Q2
$733K Sell
1,384
-795
-36% -$367K 0.01% 920
2026
Q1
$1.05M Buy
2,179
+18
+0.8% +$9.22K 0.01% 747
2025
Q4
$1.21M Sell
2,161
-27
-1% -$15.3K 0.01% 644
2025
Q3
$1.12M Buy
2,188
+981
+81% +$428K 0.01% 646
2025
Q2
$379K Buy
1,207
+6
+0.5% +$1.8K ﹤0.01% 934
2025
Q1
$366K Buy
1,201
+36
+3% +$12.1K 0.01% 887
2024
Q4
$387K Buy
1,165
+23
+2% +$7.8K 0.01% 911
2024
Q3
$381K Buy
1,142
+798
+232% +$303K 0.01% 886
2024
Q2
$142K Sell
344
-29
-8% -$11.5K 0.03% 381
2024
Q1
$151K Buy
373
+15
+4% +$5.27K 0.03% 374
2023
Q4
$110K Buy
358
+110
+44% +$29.7K 0.02% 403
2023
Q3
$60K Hold
248
– – 0.01% 438
2023
Q2
$60K Buy
+248
New +$51.5K 0.01% 443

Other funds holding MEDP

Benjamin Edwards's MEDP Position: Q3 2026 in Review

Benjamin Edwards reduced its Medpace (MEDP) stake by 24% in Q3 2026, selling an estimated $193K and leaving 1,054 shares worth $658K. The position accounts for 0.01% of the portfolio, ranked #964.

Benjamin Edwards first reported a position in MEDP in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.21M in Q4 2025. 619 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Benjamin Edwards held 1,054 shares of Medpace worth $658K as of Q3 2026.
  • Benjamin Edwards sold 330 Medpace shares in Q3 2026, an estimated $193K.
  • Medpace made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #964 holding.
  • Benjamin Edwards first reported a position in Medpace in Q2 2023 and has held it in 14 quarters since.
  • Benjamin Edwards's Medpace position peaked at $1.21M in Q4 2025.
  • 619 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.